<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03770091</url>
  </required_header>
  <id_info>
    <org_study_id>STUDY18090019</org_study_id>
    <nct_id>NCT03770091</nct_id>
  </id_info>
  <brief_title>Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis</brief_title>
  <official_title>Impact of Theraworx Foam on Pain and Motion and Patient-Reported Outcomes in Thumb Arthritis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John Fowler</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40,&#xD;
      which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are&#xD;
      both conservative and surgical with surgical options including osteotomy, bone excision,&#xD;
      ligament reconstruction, and various prosthetic implants. The conservative treatment options,&#xD;
      however, are limited to NSAIDs and bracing or steroid injections.&#xD;
&#xD;
      Advances in topical therapies have the potential to deliver focused treatment to the CMC&#xD;
      joint. Novel treatment of inflammation can potentially reduce inflammation and pain&#xD;
      associated with progressing osteoarthritis. Theraworx Relief is an FDA registered foam that&#xD;
      has theoretical impact on inflammation reduction in human subjects treated with the topical&#xD;
      foam.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This pilot study seeks to investigate potential benefit in the use of Theraworx Foam in&#xD;
      patients diagnosed with thumb CMC OA. Patients presenting to the upper extremity orthopedic&#xD;
      surgery clinic for thumb/hand/wrist pain will be diagnosed by a Board Certified Hand Surgeon&#xD;
      as per standard protocols. Patients who are recommended to follow a conservative treatment&#xD;
      modality and are interested in participating in this study will be randomized into treatment&#xD;
      or control groups. Both groups will undergo symptom assessment, strength testing, and range&#xD;
      of motion testing prior to starting the standard conservative treatment of bracing. The&#xD;
      treatment group will use the TheraWorx topical foam and the compression wrap nightly for 2&#xD;
      weeks for at least 6 hours per night. Control group will use a compression wrap for the same&#xD;
      time period. Both groups will return at 1 and 2 weeks for repeat strength and range of motion&#xD;
      testing and symptom assessment.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 21, 2018</start_date>
  <completion_date type="Actual">August 1, 2020</completion_date>
  <primary_completion_date type="Actual">July 30, 2020</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Numeric Pain Rating Scale</measure>
    <time_frame>2 weeks</time_frame>
    <description>patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain). The mean score at 2 weeks is reported, not the change from baseline.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Disabilities of the Arm, Shoulder, and Hand (DASH) Score</measure>
    <time_frame>2 weeks</time_frame>
    <description>patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, mean value at 2 weeks is reported</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Thumb Range of Motion</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), 2 week data is presented as a mean.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Grip Strength</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), mean grip strength in pounds reported at 2 weeks</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pinch Strength</measure>
    <time_frame>2 weeks</time_frame>
    <description>This measures pinch strength in pounds (0 is no pinch strength and 40 is maximum pinch strength), mean pinch in pounds reported at 2 weeks</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">40</enrollment>
  <condition>Arthritis</condition>
  <arm_group>
    <arm_group_label>Foam and Compression Wrap</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will use Theraworx foam and a compression wrap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Foam and Compression Wrap</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients will use placebo foam and a compression wrap</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Foam alone</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will use Theraworx foam without compression wrap</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Theraworx</intervention_name>
    <description>Theraworx foam applied to skin and/or compression wrap</description>
    <arm_group_label>Foam alone</arm_group_label>
    <arm_group_label>Foam and Compression Wrap</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Placebo foam</description>
    <arm_group_label>Placebo Foam and Compression Wrap</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Thumb CMC arthritis&#xD;
&#xD;
          2. greater than or equal to age 18&#xD;
&#xD;
          3. Interested in non-operative treatment of thumb arthritis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Recent corticosteroid injection into the thumb joint&#xD;
&#xD;
          2. Non-English speaking&#xD;
&#xD;
          3. skin lesions or rashes on the thumb&#xD;
&#xD;
          4. current use of topical anti-inflammatory medications&#xD;
&#xD;
          5. concomitant thumb/wrist diagnoses that would impact the results (as determined by the&#xD;
             PI)&#xD;
&#xD;
          6. known allergy to magnesium&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John R Fowler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Univ. of Pittsburgh Orthopaedic Surgery</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaufmann Building</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Montefiore Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 6, 2018</study_first_submitted>
  <study_first_submitted_qc>December 6, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 10, 2018</study_first_posted>
  <results_first_submitted>June 12, 2021</results_first_submitted>
  <results_first_submitted_qc>July 13, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 14, 2021</results_first_posted>
  <last_update_submitted>July 13, 2021</last_update_submitted>
  <last_update_submitted_qc>July 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Pittsburgh</investigator_affiliation>
    <investigator_full_name>John Fowler</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Allantoin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>August 1, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/91/NCT03770091/Prot_SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Foam and Compression Wrap</title>
          <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
        <group group_id="P2">
          <title>Placebo Foam and Compression Wrap</title>
          <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
        </group>
        <group group_id="P3">
          <title>Foam Alone</title>
          <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="15"/>
                <participants group_id="P2" count="13"/>
                <participants group_id="P3" count="12"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
                <participants group_id="P3" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Foam and Compression Wrap</title>
          <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
        <group group_id="B2">
          <title>Placebo Foam and Compression Wrap</title>
          <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
        </group>
        <group group_id="B3">
          <title>Foam Alone</title>
          <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="15"/>
            <count group_id="B2" value="13"/>
            <count group_id="B3" value="12"/>
            <count group_id="B4" value="40"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="8"/>
                    <measurement group_id="B3" value="8"/>
                    <measurement group_id="B4" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="4"/>
                    <measurement group_id="B4" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61" spread="10"/>
                    <measurement group_id="B2" value="60" spread="8"/>
                    <measurement group_id="B3" value="60" spread="9"/>
                    <measurement group_id="B4" value="60" spread="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="38"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="1"/>
                    <measurement group_id="B4" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="11"/>
                    <measurement group_id="B3" value="11"/>
                    <measurement group_id="B4" value="35"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="13"/>
                    <measurement group_id="B3" value="12"/>
                    <measurement group_id="B4" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Numeric Pain Rating Scale</title>
        <description>patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain). The mean score at 2 weeks is reported, not the change from baseline.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foam and Compression Wrap</title>
            <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
          <group group_id="O2">
            <title>Placebo Foam and Compression Wrap</title>
            <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
          </group>
          <group group_id="O3">
            <title>Foam Alone</title>
            <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
        </group_list>
        <measure>
          <title>Numeric Pain Rating Scale</title>
          <description>patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain). The mean score at 2 weeks is reported, not the change from baseline.</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.7" spread="1.3"/>
                    <measurement group_id="O2" value="2.4" spread="1.5"/>
                    <measurement group_id="O3" value="3.2" spread="2.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>ANOVA performed</non_inferiority_desc>
            <p_value>0.6</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Disabilities of the Arm, Shoulder, and Hand (DASH) Score</title>
        <description>patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, mean value at 2 weeks is reported</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foam and Compression Wrap</title>
            <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
          <group group_id="O2">
            <title>Placebo Foam and Compression Wrap</title>
            <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
          </group>
          <group group_id="O3">
            <title>Foam Alone</title>
            <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
        </group_list>
        <measure>
          <title>Disabilities of the Arm, Shoulder, and Hand (DASH) Score</title>
          <description>patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, mean value at 2 weeks is reported</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.8" spread="10.9"/>
                    <measurement group_id="O2" value="35.9" spread="17.1"/>
                    <measurement group_id="O3" value="26.35" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.59</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Thumb Range of Motion</title>
        <description>This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), 2 week data is presented as a mean.</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foam and Compression Wrap</title>
            <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
          <group group_id="O2">
            <title>Placebo Foam and Compression Wrap</title>
            <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
          </group>
          <group group_id="O3">
            <title>Foam Alone</title>
            <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
        </group_list>
        <measure>
          <title>Thumb Range of Motion</title>
          <description>This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), 2 week data is presented as a mean.</description>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="70" spread="10"/>
                    <measurement group_id="O2" value="60" spread="12"/>
                    <measurement group_id="O3" value="70" spread="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.9</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Grip Strength</title>
        <description>This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), mean grip strength in pounds reported at 2 weeks</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foam and Compression Wrap</title>
            <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
          <group group_id="O2">
            <title>Placebo Foam and Compression Wrap</title>
            <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
          </group>
          <group group_id="O3">
            <title>Foam Alone</title>
            <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
        </group_list>
        <measure>
          <title>Grip Strength</title>
          <description>This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), mean grip strength in pounds reported at 2 weeks</description>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="74" spread="9.6"/>
                    <measurement group_id="O2" value="67" spread="8.7"/>
                    <measurement group_id="O3" value="72" spread="9.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.45</p_value>
            <method>ANCOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pinch Strength</title>
        <description>This measures pinch strength in pounds (0 is no pinch strength and 40 is maximum pinch strength), mean pinch in pounds reported at 2 weeks</description>
        <time_frame>2 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Foam and Compression Wrap</title>
            <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
          <group group_id="O2">
            <title>Placebo Foam and Compression Wrap</title>
            <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
          </group>
          <group group_id="O3">
            <title>Foam Alone</title>
            <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
          </group>
        </group_list>
        <measure>
          <title>Pinch Strength</title>
          <description>This measures pinch strength in pounds (0 is no pinch strength and 40 is maximum pinch strength), mean pinch in pounds reported at 2 weeks</description>
          <units>pounds</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="15"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5" spread="10.5"/>
                    <measurement group_id="O2" value="29" spread="17.1"/>
                    <measurement group_id="O3" value="25" spread="14.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.5</p_value>
            <method>ANOVA</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Collected information on reactions to foam or placebo over course of study (2 weeks)</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Foam and Compression Wrap</title>
          <description>Patients will use Theraworx foam and a compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
        <group group_id="E2">
          <title>Placebo Foam and Compression Wrap</title>
          <description>Patients will use placebo foam and a compression wrap&#xD;
Placebo: Placebo foam</description>
        </group>
        <group group_id="E3">
          <title>Foam Alone</title>
          <description>Patients will use Theraworx foam without compression wrap&#xD;
Theraworx: Theraworx foam applied to skin and/or compression wrap</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="15"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="13"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>John Fowler</name_or_title>
      <organization>UPMC</organization>
      <phone>412-605-3245</phone>
      <email>fowlerjr@upmc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

